Close

content

U.S. Government Exercises 1st Option for Additional 100 Million Doses of Moderna’s COVID-19 Vaccine Candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...

AstraZeneca reports Trixeo Aerosphere approved in EU for COPD maintenance

AstraZeneca’s Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary...

Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2...

SpiceXpress strengthens pharma cold chain capabilities with Om partnership

SpiceXpress, the cargo division of India-based carrier SpiceJet, has partnered with Om Logistics to strengthen its capabilities to transport temperature-sensitive Covid-19 vaccines. The carrier said...

UPS To Support Distribution Of Approved Vaccine As Part Of Operation Warp Speed

UPS announced its involvement and full support of distribution efforts for Pfizer-BioNTech’s COVID-19 vaccine as part of Operation Warp Speed. Pfizer’s and BioNTech’s vaccine,...

FedEx to Ship First Wave of COVID-19 Vaccines Across the United States

FedEx Express, a subsidiary of FedEx Corp. and the world’s largest express transportation company, announced that operations are in motion to transport its first...

Sanofi, GSK COVID-19 vaccine rollout delayed on low immune response in older adults

Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read